Atlas Trials

Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)

Clinical trial NCT03612869 · UNKNOWN

Trial details

NCT number
NCT03612869
Sponsor
LYSOGENE
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Mucopolysaccharidosis Type IIIA
Start date
2018-12-17
Primary completion
2022-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.